QIN Jing, ZHU Qingli. Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 130-134. DOI: 10.12290/xhyxzz.2023-0306
Citation: QIN Jing, ZHU Qingli. Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 130-134. DOI: 10.12290/xhyxzz.2023-0306

Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound

Funds: 

National High-Level Hospital Clinical Research Funding 2022-PUMCH-C-018

National Natural Science Foundation of China 81791640

More Information
  • Corresponding author:

    ZHU Qingli, E-mail: zqlpumch@126.com

  • Received Date: June 26, 2023
  • Accepted Date: July 30, 2023
  • Issue Publish Date: January 29, 2024
  • Crohn's disease (CD) is a chronic inflammatory bowel disease with complicated pathogenesis and prolonged condition. In recent years, with the development of targeted therapy, biological agents have been widely used in the treatment of CD, which has significantly improved the prognosis of CD patients. If the efficacy evaluation can be carried out at the early stage of targeted therapy, it may help to figure out the patients who can benefit from the treatment and optimize the treatment plan for the ineffective patients in time. In the evaluation of CD activity and efficacy, ultrasound has the advantages of high accuracy, no radiation and high patient acceptance, and therefore has potential clinical application value in the early efficacy evaluation of CD targeted therapy. This article reviews the research progress to provides a reference for optimizing the treatment plan for CD patients.
  • [1]
    Lichtenstein G R, Loftus E V, Isaacs K L, et al. ACG clinical guideline: management of Crohn's disease in adults[J]. Am J Gastroenterol, 2018, 113(4): 481-517. DOI: 10.1038/ajg.2018.27
    [2]
    Ilvemark J F K F, Hansen T, Goodsall T M, et al. Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement[J]. J Crohns Colitis, 2022, 16(4): 554-580. DOI: 10.1093/ecco-jcc/jjab173
    [3]
    Drews B H, Barth T F E, Hänle M M, et al. Comparison of sonographically measured bowel wall vascularity, histo-logy, and disease activity in Crohn's disease[J]. Eur Radiol, 2009, 19(6): 1379-1386. DOI: 10.1007/s00330-008-1290-5
    [4]
    Novak K L, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score[IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn's disease[J]. J Crohns Colitis, 2021, 15(4): 609-616. DOI: 10.1093/ecco-jcc/jjaa216
    [5]
    Dragoni G, Gottin M, Innocenti T, et al. Correlation of ultrasound scores with endoscopic activity in Crohn's disease: a prospective exploratory study[J]. J Crohns Colitis, 2023, 17(9): 1387-1394. DOI: 10.1093/ecco-jcc/jjad068
    [6]
    Bots S, Nylund K, Löwenberg M, et al. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores[J]. J Crohns Colitis, 2018, 12(8): 920-929. DOI: 10.1093/ecco-jcc/jjy048
    [7]
    Goodsall T M, Nguyen T M, Parker C E, et al. Systematic review: gastrointestinal ultrasound scoring indices for inflammatory bowel disease[J]. J Crohns Colitis, 2021, 15(1): 125-142. DOI: 10.1093/ecco-jcc/jjaa129
    [8]
    Castiglione F, Mainenti P, Testa A, et al. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents[J]. Dig Liver Dis, 2017, 49(5): 484-489. DOI: 10.1016/j.dld.2017.02.014
    [9]
    Castiglione F, Testa A, Rea M, et al. Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics[J]. Inflamm Bowel Dis, 2013, 19(9): 1928-1934.
    [10]
    Orlando S, Fraquelli M, Coletta M, et al. Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn's disease treated with anti-tumour necrosis factor antibodies[J]. J Crohns Colitis, 2018, 12(1): 63-70. DOI: 10.1093/ecco-jcc/jjx116
    [11]
    De Voogd F, Bots S, Gecse K, et al. Intestinal ultrasound early on in treatment follow-up predicts endoscopic response to anti-TNFα treatment in Crohn's disease[J]. J Crohns Colitis, 2022, 16(10): 1598-1608. DOI: 10.1093/ecco-jcc/jjac072
    [12]
    Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography tight control and monitoring in Crohn's disease during different biological therapies: a multicenter study[J]. Clin Gastroenterol Hepatol, 2022, 20(4): e711-e722. DOI: 10.1016/j.cgh.2021.03.030
    [13]
    Paredes J M, Moreno N, Latorre P, et al. Clinical impact of sonographic transmural healing after anti-TNF antibody treatment in patients with Crohn's disease[J]. Dig Dis Sci, 2019, 64(9): 2600-2606. DOI: 10.1007/s10620-019-05567-w
    [14]
    Kucharzik T, Wittig B M, Helwig U, et al. Use of intestinal ultrasound to monitor Crohn's disease activity[J]. Clin Gastroenterol Hepatol, 2017, 15(4): 535-542. e2. DOI: 10.1016/j.cgh.2016.10.040
    [15]
    Ripollés T, Paredes J M, Martínez-Pérez M J, et al. Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn's disease: a multicenter study[J]. Inflamm Bowel Dis, 2016, 22(10): 2465-2473. DOI: 10.1097/MIB.0000000000000882
    [16]
    Paredes J M, Ripollés T, Cortés X, et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease[J]. Dig Dis Sci, 2010, 55(2): 404-410. DOI: 10.1007/s10620-009-0759-7
    [17]
    Goertz R S, Klett D, Wildner D, et al. Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study[J]. Acta radiol, 2018, 59(10): 1149-1156. DOI: 10.1177/0284185117752032
    [18]
    Quaia E, Sozzi M, Angileri R, et al. Time-intensity curves obtained after microbubble injection can be used to differentiate responders from nonresponders among patients with clinically active Crohn disease after 6 weeks of pharmacologic treatment[J]. Radiology, 2016, 281(2): 606-616. DOI: 10.1148/radiol.2016152461
    [19]
    Quaia E, Gennari A G, Cova M A. Early predictors of the long-term response to therapy in patients with Crohn disease derived from a time-intensity curve analysis after microbub-ble contrast agent injection[J]. J Ultrasound Med, 2019, 38(4): 947-958. DOI: 10.1002/jum.14778
    [20]
    Saevik F, Nylund K, Hausken T, et al. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease[J]. Inflamm Bowel Dis, 2014, 20(11): 2029-2037. DOI: 10.1097/MIB.0000000000000159
    [21]
    Baumgart D C, Müller H P, Grittner U, et al. US-based real-time elastography for the detection of fibrotic gut tissue in patients with stricturing Crohn disease[J]. Radiology, 2015, 275(3): 889-899.
    [22]
    Chen Y J, Chen B L, Liang M J, et al. Longitudinal bowel behavior assessed by bowel ultrasound to predict early response to anti-TNF therapy in patients with Crohn's disease: a pilot study[J]. Inflamm Bowel Dis, 2022, 28(Suppl 2): S67-S75.
  • Related Articles

    [1]XUE Jianjun, WANG Caihong, GUO Lingling, LI Xiuxia, ZHANG Jie, XU Ziqing, HOU Huaijing, YANG Kehu. Evidence Graph Analysis of Postoperative Pain Sensitization Induced by Perioperative Sleep Deprivation[J]. Medical Journal of Peking Union Medical College Hospital, 2025, 16(1): 143-156. DOI: 10.12290/xhyxzz.2024-0075
    [2]ZHU Di, LUO Xufei, WANG Zijun, SHI Qianling, LI Haodong, WANG Ye, CHEN Yaolong. The Differences and Connections Among Expert Evidence, Expert Opinion and Expert Consensus in the Development of Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 936-941. DOI: 10.12290/xhyxzz.2024-0542
    [3]LI Zhiyong, WANG Jing, ZHOU Yali, YUAN Dong. Research Progress in Blood Pressure Management after Aortic Dissection[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 904-910. DOI: 10.12290/xhyxzz.2023-0643
    [4]SHI Qianling, LIU Hui, WANG Zijun, LUO Xufei, WANG Bingyi, YANG Nan, MENG Wenbo, CHEN Yaolong. How to Correctly Understand and Use the Low-quality Evidence to Formulate Recommendations in Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 676-685. DOI: 10.12290/xhyxzz.2024-0278
    [5]LAI Honghao, WANG Zhe, LI Ying, TANG Wenjing, WANG Beibei, SUN Peidong, SUN Mingyao, HUANG Jiajie, XIAO Zhipan, LI Ying, ZHAO Chen, SHANG Hongcai, YANG Kehu, LIU Jie, GE Long. Multi-evidence Integration Methodology for Traditional Chinese Medicine: the MERGE Framework[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 172-182. DOI: 10.12290/xhyxzz.2023-0083
    [6]SU Renfeng, YU Xuan, SHI Qianling, LUO Xufei, SUN Yajia, LAN Hui, REN Mengjuan, WU Shouyuan, WANG Ping, WANG Ling, ZHAO Junxian, CHEN Yaolong. Current Situation and Progress of Evidence Synthesis Methodology[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1301-1309. DOI: 10.12290/xhyxzz.2023-0062
    [7]LIU Yunlan, REN Mengjuan, WANG Zijun, SU Renfeng, LUO Xufei, GUO Qiangqiang, YU jing, XING Aijun, ZHOU Xiaoyang, CHEN Yaolong. Comparative Analysis of Recommendations for Timingand Frequency of Home Blood Pressure Monitoring in Clinical Practice Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 399-408. DOI: 10.12290/xhyxzz.2022-0664
    [8]Qing-hai WANG, Shi-cheng LI, Yan-xiang WU, Chen-yu WANG, Xiao-wei YAN. Correlation between 24-hour Urinary Sodium Excretion and the Status of Blood Pressure Control in Patients with Resistant Hypertension: A Single-center Cross-sectional Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 127-132. DOI: 10.3969/j.issn.1674-9081.2019.02.008
    [9]Ling LI, Li-gang FANG. Pay Attention to the Treatment and Management of Hypertension in the Elderly[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(2): 112-116. DOI: 10.3969/j.issn.1674-9081.2019.02.005
    [10]Xiao-qing LIU, Xiao-chuan SUN. Real-world Evidence[J]. Medical Journal of Peking Union Medical College Hospital, 2017, 8(4-5): 305-310. DOI: 10.3969/j.issn.1674-9081.2017.05.021

Catalog

    Article Metrics

    Article views (181) PDF downloads (51) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close